History | Bladder cancer: diagnosis and management | Guidance | NICE

Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

History

Stakeholder list updated

Stakeholder list (PDF 113 KB)

Published:

05 April 2019

Surveillance consultation

Surveillance consultation
Surveillance review proposal (PDF 997 KB)

Published:

12 February 2019
Comments form (MSWord 27 KB)

Published:

12 February 2019

Draft scope consultation

Draft scope consultation
Draft scope (PDF 123 KB)

Published:

19 July 2012
Stakeholder list (PDF 45 KB)

Published:

15 February 2013

Equality impact assessment

Equality impact assessment (PDF 105 KB)

Published:

25 February 2015

Consultation comments table

Consultation comments table (PDF 1.06 MB)

Published:

25 February 2015

Guideline development and consultation

Guideline development and consultation
Guideline consultation information
Evidence review (PDF 9.41 MB)

Published:

03 September 2014
Needs assessment (PDF 3.17 MB)

Published:

03 September 2014
Comments proforma (MSWord 53 KB)

Published:

02 September 2014
NICE Guideline draft for consultation (PDF 397 KB)

Published:

02 September 2014
Clinical Guideline Draft for Consultation (PDF 7.43 MB)

Published:

02 September 2014
Search strategies (PDF 499 KB)

Published:

04 August 2014
Review questions (PDF 30 KB)

Published:

04 August 2014
Health economic plan (PDF 38 KB)

Published:

04 August 2014
GDG minutes
GDG 14 10-11 November 2014 (PDF 13 KB)

Published:

23 February 2015
GDG 13 - 16-17 June 2014 (PDF 89 KB)

Published:

23 February 2015
GDG 7 - 8 May 2014 (PDF 34 KB)

Published:

17 July 2014
GDG 11- 4 April 2014 (PDF 15 KB)

Published:

05 June 2014
GDG 10 - 27 Feb 2014 (PDF 29 KB)

Published:

05 June 2014
GDG 9 14-15 Jan 2014 (PDF 91 KB)

Published:

05 June 2014
GDG 8 - 4 November 2013 (PDF 29 KB)

Published:

05 June 2014
GDG 7 - 17 & 18 September 2013 (PDF 90 KB)

Published:

05 June 2014
GDG 6 - 18th July 2013 (PDF 89 KB)

Published:

05 June 2014
GDG 5 - 7 June 2013 (PDF 77 KB)

Published:

30 August 2013
GDG 4 - 23 April 2013 (PDF 76 KB)

Published:

19 July 2013
GDG 3 - 25 February 2013 (PDF 117 KB)

Published:

19 July 2013
GDG 2 - 6 December 2012 (PDF 74 KB)

Published:

04 March 2013
GDG 1 - 18 and 19 October 2012 (PDF 36 KB)

Published:

04 March 2013
GDG membership list (PDF 72 KB)

Published:

12 October 2012

Scoping workshop and final scope

Scoping workshop and final scope
Equalities assessment form (PDF 239 KB)

Published:

17 October 2012
Final scope (PDF 129 KB)

Published:

12 October 2012
Scope consultation table with responses (PDF 314 KB)

Published:

12 October 2012
Scoping workshop summary notes (PDF 125 KB)

Published:

12 October 2012

List of registered stakeholders

List of registered stakeholders (PDF 45 KB)

Published:

15 February 2013